Publication Date:
1996-03-15
Description:
A new mathematical model was used to analyze a detailed set of human immunodeficiency virus-type 1 (HIV-1) viral load data collected from five infected individuals after the administration of a potent inhibitor of HIV-1 protease. Productively infected cells were estimated to have, on average, a life-span of 2.2 days (half-life t 1/2 = 1.6 days), and plasma virions were estimated to have a mean life-span of 0.3 days (t 1/2 = 0.24 days). The estimated average total HIV-1 production was 10.3 x 10(9) virions per day, which is substantially greater than previous minimum estimates. The results also suggest that the minimum duration of the HIV-1 life cycle in vivo is 1.2 days on average, and that the average HIV-1 generation time--defined as the time from release of a virion until it infects another cell and causes the release of a new generation of viral particles--is 2.6 days. These findings on viral dynamics provide not only a kinetic picture of HIV-1 pathogenesis, but also theoretical principles to guide the development of treatment strategies.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Perelson, A S -- Neumann, A U -- Markowitz, M -- Leonard, J M -- Ho, D D -- AI27742/AI/NIAID NIH HHS/ -- N01 AI45218/AI/NIAID NIH HHS/ -- RR06555/RR/NCRR NIH HHS/ -- etc. -- New York, N.Y. -- Science. 1996 Mar 15;271(5255):1582-6.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Theoretical Division, Los Alamos National Laboratory, NM 87545, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/8599114" target="_blank"〉PubMed〈/a〉
Keywords:
Antiviral Agents/administration & dosage/therapeutic use
;
CD4 Lymphocyte Count
;
CD4-Positive T-Lymphocytes/*cytology/*virology
;
Cell Survival
;
HIV Infections/drug therapy/*virology
;
HIV Protease Inhibitors/administration & dosage/therapeutic use
;
HIV-1/drug effects/*physiology
;
Half-Life
;
Humans
;
Kinetics
;
Models, Biological
;
RNA, Viral/blood
;
Regression Analysis
;
Ritonavir
;
Thiazoles/administration & dosage/therapeutic use
;
Valine/administration & dosage/analogs & derivatives/therapeutic use
;
Viremia
;
Virion/drug effects/*physiology
;
Virus Replication
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink